M&A / Deals Deep Science Ventures and MDC partner to accelerate brain treatments PharmaTimesNew collaboration aims to break barriers in braintargeted drug discoveryNeuroscienceRead full story pharminent June 2, 2026 (Last updated: June 4, 2026) PharmaTimes New collaboration aims to break barriers in braintargeted drug discovery Neuroscience Read full story Post navigation Previous: BMS secures FDA acceptance for Camzyos sNDANext: Abivax slides on phase 3 data in ulcerative colitis Related Stories M&A / Deals Ono Pharmaceutical joins forces with Aitia for drug discovery in neurology pharminent September 2, 2026 M&A / Deals Lilly adds to immune drug pipeline with $2.9B Merida buyout pharminent August 31, 2026 M&A / Deals Acquisitive Lilly offers $2.88bn for Merida Bio pharminent August 31, 2026